CorMedix Inc. (CRMD)
NASDAQ: CRMD · Real-Time Price · USD
7.13
-0.22 (-2.99%)
At close: Feb 27, 2026, 4:00 PM EST
7.19
+0.06 (0.89%)
After-hours: Feb 27, 2026, 7:58 PM EST

CorMedix Market Cap

CorMedix has a market cap or net worth of $561.77 million as of February 27, 2026. Its market cap has decreased by -7.42% in one year.

Market Cap
561.77M
Enterprise Value
654.97M
1-Year Change
-7.42%
Ranking
Category
Stock Price
$7.13

Market Cap Chart

Since May 13, 2010, CorMedix's market cap has increased from $34.20M to $561.77M, an increase of 1,542.59%. That is a compound annual growth rate of 19.37%.

History

DateMarket Cap% Change
Feb 27, 2026561.80M-38.69%
Dec 31, 2025916.30M86.43%
Dec 31, 2024491.50M138.48%
Dec 29, 2023206.10M18.31%
Dec 30, 2022174.20M0.52%
Dec 31, 2021173.30M-27.40%
Dec 31, 2020238.70M27.78%
Dec 31, 2019186.80M37.45%
Dec 31, 2018135.90M304.46%
Dec 29, 201733.60M-45.72%
Dec 30, 201661.90M-13.79%
Dec 31, 201571.80M67.76%
Dec 31, 201442.80M114.00%
Dec 31, 201320.00M143.90%
Dec 31, 20128.20M156.25%
Dec 30, 20113.20M-84.62%
Dec 31, 201020.80M-39.18%
View and export this data all the way back to 2010. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
LB Pharmaceuticals 615.27M
Ocugen 609.87M
MeiraGTx Holdings 607.71M
Design Therapeutics 604.67M
Zura Bio 602.94M
Neumora Therapeutics 599.88M
Allogene Therapeutics 595.53M
Fulcrum Therapeutics 580.75M
Market Cap Rankings